VHFMoDRAD in numbers

13 Organisations

0

Institutes

0

SMEs

0

Large company

0

NGO

0

Private company

Details

0

Year duration, start January 1st, 2019

0

€ IMI2 JU Contribution

0

€ Industrial Contribution

VHFMoDRAD is a four-year European project (Collaborative Research Project) and is part of IMI’s EBOLA+ programme that was launched in 2014 to respond to the Ebola epidemic by accelerating all aspects of vaccine development and diagnostics. The project has started in January 2019 and is coordinated by Folkhälsomyndigheten (the Public Health Agency of Sweden, FoHM) represented by Professor Ali Mirazimi. The consortium brings together:

  1. 1) operational capacity with appropriate facilities,
  2. 2) experienced researchers,
  3. 3) authorities and entities,
  4. 4) clinical samples from endemic countries,
  5. 5) access to diagnostic hubs in epidemic areas,
  6. 6) a strong industrial partner, CEPHEID
  7. 7) SMEs and
  8. 8) an international network.

The project is supported by the EU’s research and innovation programme and CEPHEID Europe SAS through the Innovative Medicines Initiative (IMI). Two companies and consortium partners, Coris Bioconcept and RD Biotech, also provide financial support to the project.

The consortium

Europe
France

- RD-Biotech (RD-B), Jean-Luc Schlick
- CEPHEID EUROPE SAS, Dave Persing
- Institut national de la Santé et de la recherche médicale (INSERM), Hervé Raoul
- Aix-Marseille University (AMU), Rémi Charrel
- Inserm Transfert (IT), Sinéad Quigley
Belgium

- RD-Biotech (RD-B), Jean-Luc Schlick
- CEPHEID EUROPE SAS, Dave Persing
- Institut national de la Santé et de la recherche médicale (INSERM), Hervé Raoul
- Aix-Marseille University (AMU), Rémi Charrel
- Inserm Transfert (IT), Sinéad Quigley
Italy

- Istituto Nazionale per le Malattie Infettive "L. Spallanzani" I.R.C.C.S (INMI), Antonino Di Caro
- Emergency (EMR), Gina Portella
Denmark

- University of Copenhagen (UCPH), Ola Blixt
Sweden

IPD Institut Pasteur de Dakar (IPD), Amadou Sall
United Kingdom

- University of Stirling (UoS), Manfred Weidmann
- Department of Health, Public Health England (DH-PHE), Robert Watson
Senegal

IPD Institut Pasteur de Dakar (IPD), Amadou Sall

6 EU and 1 non EU Countries

VHFMoDRAD brings together cutting-edge complementary partners, including 1 large company, 2 small and medium enterprises, one technology transfer / management company, 8 research institution, from 6 European Member States (Sweden, UK, France, Belgium, Denmark, Italy), one NGO and an African country (Senegal), who will address the challenges of development and implementation of diagnostic tools in Africa, thus reinforcing the international and national response in the face of an outbreak.

Coordination

FoHM - Sweden

Folkhälsomyndigheten -
Public health agency of Sweden
Ali Mirazimi

Sweden

13 Partners

IT - France

INSERM Transfert
Sinéad Quigley

UoS- United Kingdom

University of Stirling
Manfred Weidmann

DH-PHE- United Kingdom

Department of Health,
Public Health England
Nadina Wand

CORIS- Belgium

Coris BioConcept SPRL
Pascal Mertens

INSERM - France

Institut national de la santé et de la recherche médicale
Hervé Raoul

UCPH- Denmark

University of Copenhagen
Ola Blixt

INMI- Italy

Istituto Nazionale per le Malattie Infettive "L. Spallanzani" I.R.C.C.S
Antonino Di Caro

IPD- Senegal

Institut Pasteur de Dakar
Amadou Sall

RD-B- France

RD-Biotech
Jean-Luc Schlick

CEPHEID- France

CEPHEID
Dave Persing

AMU- France

Université Aix Marseille
Rémi Charrel

EMR- Italy

Emergency
Gina Portella